The U.S. FDA approved Basaglar (insulin glargine injection), the newest diabetes treatment from the Lilly-Boehringer Ingelheim diabetes…
A U.S. FDA safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors (such as Invokana, Farxiga and Jardiance) about the risks of too much acid in the blood and of serious urinary tract infections. Both conditions can result in hospitalization.
We're thrilled to be partnering with Casabella, Silpat, PackIt, and KitchenIQ to give you a chance to win these lovely (and useful) products.
Dear Reader,
Black Friday and Cyber Monday, two of the busiest shopping days of the year, are just around the corner.
If you intend to shop on…
Happy World Diabetes Awareness Month! This year ASweetLife has teamed up with All Day I Dream About Food, Low Carb Yum, KetoDietApp, and SugarFreeMom…
Jill Weissberg-Benchell, a psychologist and CDE in Chicago is inviting people with T1D and their loved ones (partners, spouses, parents) to participate…
The organisation T1International is calling for insulin and other vital diabetes supplies? ?to be made available for everyone with diabetes as part of their World Diabetes Day campaign.
The #insulin4all? campaign is led by T1International? and ?a charity partnership group called? ?The Access Alliance?.
Covalent Data, Inc. announced an agreement that provides JDRF with the ability to track and analyze the resultant output of grant awards to academic researchers. JDRF has helped direct more than $2 billion in research funding since its inception.
Medtronic has announced that it will no longer sell its CGM Sof-sensor as of Dec. 1, 2015. Medtronic is offering no out of pocket cost conversion programs to their latest insulin pump and CGM technology, the MiniMed 530G with Enlite.
More than two years after dealing Novo Nordisk a surprising setback, the U.S. Food and Drug Administration has approved Tresiba (insulin degludec…